|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology, University of Munich, 80336 Munich, Germany; and 2 Department of Biology, Technion, Haifa, Israel
| |
ABSTRACT |
|---|
|
|
|---|
The effect of xanthine derivatives
on the voltage-activated Cl
conductance
(GCl) of amphibian skin was analyzed.
3-Isobutyl-1-methylxanthine (IBMX) and the recently synthesized
xanthine derivatives 3,7-dimethyl-1-propyl xanthine (X-32) and
3,7-dimethyl-1-isobutyl xanthine (X-33), which lack inhibitory effects
on phosphodiesterases in CHO and Calu-3 cells, increased
voltage-activated GCl without effect on baseline conductance at inactivating voltage. Half-maximal stimulation of
GCl occurred at 108 ± 9 µM for X-32 and
X-33 after apical or basolateral application. The stimulation of
GCl, which occurs only in the presence of
Cl
in the mucosal solution, is caused by a shift of the
voltage sensitivity to lower clamp potentials and an increase of the
maximally activated level. Furosemide reversed both the shift of
sensitivity and the increase in magnitude. These patterns are
fundamentally different from those seen after application of
membrane-permeant, nonmetabolized analogs of cAMP, and they indicate
that the xanthines stimulate GCl directly. This
notion is strengthened by the lack of influence on intracellular cAMP
content, which is consistent with the observations in CHO and Calu-3
cells. We propose that the xanthine derivatives increase the voltage
sensitivity of a regulative component in the conductive
Cl
pathway across amphibian skin.
Bufo viridis; furosemide; 3-isobutyl-1-methylxanthine; mitochondria-rich cells
| |
INTRODUCTION |
|---|
|
|
|---|
DESPITE CONTINUED
INVESTIGATION over the past 20 years the mode and regulation of
Cl
transport across amphibian skin have still not been
resolved (for references see Refs. 8, 14,
16). The amphibian skin is a multilayered, heterocellular
epithelium, and at least four routes for Cl
movement
(principal cells, glands, mitochondria-rich cells, and paracellular
pathways) must be considered. Principal cells can be excluded with
certainty, because experimental data indicate negligible
Cl
conductance (GCl) across either
apical or basolateral membranes under control or stimulated conditions
(4, 16-18, 24). Glands secrete Cl
after
stimulation with
-adrenergic agonists (15), but they cannot account for the enormous GCl that
prevails spontaneously under short-circuit conditions (12)
or that can be activated by voltage perturbation (13, 18).
Mitochondria-rich cells or tight junctions between the cells of the
outer living layer are the remaining candidates for this fraction of
Cl
movement. To refine the search for the mechanism of
GCl, attempts have been made to identify
regulatory factors in amphibian skin. In light of the observation that
an inhibitor of phosphodiesterases (PDE), theophylline, stimulates
GCl, the involvement of cAMP was proposed
(10, 11). Such an effect is consistent with many observations in other tissues in which cAMP stimulates Cl
channels. Although the idea that cAMP may activate a conductive Cl
pathway is supported by more recent data with
membrane-permeant analogs of cAMP (9, 25), the question
remains as to whether this stimulation occurs in the range of
physiologically achieved concentrations of cAMP. Since the observation
that procaine, an agent without known effect on PDE, affects
GCl similarly to theophylline (5),
the question has arisen as to whether the stimulation of
GCl by theophylline, or the more powerful
3-isobutyl-1-methylxanthine (IBMX), actually results from the
inhibition of PDE with subsequent increase in cAMP or is due to direct
interaction of the xanthines with the Cl
pathway. Support
for the latter notion comes from the obvious difference in stimulation
pattern between cAMP and PDE inhibitors (9). Recently
synthesized xanthine derivatives without inhibitory effect on PDE
(3) provide an option for addressing this problem more
thoroughly. These agents activate the CFTR Cl
channel in
Calu-3 cells (2). We show here that the particularly effective derivatives from the above study increase the
voltage-activated GCl in toad skin, thus
corroborating the view that xanthines can interfere with
Cl
pathways without the participation of cAMP.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Experiments were performed on isolated skins of Bufo viridis. Techniques for tissue preparation and analysis of voltage-activated GCl are described elsewhere (19). In brief, abdominal skin of the toad was glued with cyanoacryl adhesive glue (Histoacryl; Braun, Melsungen, Germany) to Lucite gaskets on the basolateral side and mounted in a modified Ussing-type chamber. Edge damage was minimized by using gaskets from cured Sylgard 184 (Dow Corning, Midland, MI), which were covered with a thin layer of heavy silicone grease to seal the tissue on the mucosal side.
In experiments for the analysis of serosal effects and for
determination of cAMP content, split epithelia devoid of the connective tissue layer and glands were prepared by the collagenase method, as described recently (20). The collagenase solution was
supplemented with 0.1 mg/ml trypsin inhibitor to avoid interference
from traces of trypsin (21). Both half-chambers were
separately and continuously perfused with Ringer solution (in mM: 110 Na+, 2.5 K+, 1 Ca2+, 1 Mg2+, 114 Cl
, and 3.5 HEPES, pH = 7.5)
at 3-5 ml/min. In some experiments, Cl
of the
mucosal solution was replaced by NO

5 M
amiloride to eliminate transepithelial Na+ transport. The
exposed tissue area and the volume of the half-chambers were 0.6 cm2 and 0.4 ml, respectively. Ag/AgCl electrodes in 1 M KCl
or 1 M NaCl served for measurement of transepithelial voltage
(Vt) or for passing transepithelial current
(It) with a custom-built automatic device, which
also provided recordings of transepithelial conductance
(Gt) from the change of
It after brief, small perturbations of
Vt (5 mV, 200 ms every 2.5 s) with analog
sample-and-hold circuitry. Vt and
It are referred to the mucosal side. All data
were stored on a computer after analog to digital conversion and later
plotted with commercial graphics software (Origin; Microcal,
Northampton, MA).
For analysis of voltage-activated GCl the
tissues were alternatively voltage-clamped to
30 or +80 mV, because
we (16) and others (14) have shown that
GCl is essentially inactivated or fully
activated at these levels of Vt. The
voltage-activated GCl can therefore be obtained
as the difference between the steady-state value of
Gt at the activating holding potential (+80 mV)
and baseline Gt at the inactivating clamp
potential (
30 mV). Because of the long time constants for activation
and inactivation of GCl (1-3 min), each
determination cycle took several minutes.
Voltage-activated GCl was determined on the same
tissue pieces under control conditions and after stimulation with the
xanthines. For analysis of concentration-response dependencies, the
tissue was voltage-clamped to 80 mV to activate
GCl and the xanthines were then added in
increasing concentrations. Conductance-voltage (G-V)
relationships were determined either by clamping to increasing holding
potentials with intermittent inactivation at
30 mV or by imposing
sequentially increasing holding potentials. Because it took 3-5
min to approach a steady state at each value of
Vt (and the same time for inactivation with the
first technique), most G-V relationships were obtained with
the second method. The data were not systematically different. The
values of Gt at the clamp potentials were
plotted and fitted to a sigmoidal regression function (Origin).
Determinations under the influence of xanthines were always preceded by
measurements under control conditions for individual comparison.
The cAMP content of the epithelial cells was determined in split toad
skins glued to Lucite gaskets of 2-cm diameter. Because of the large
size of the skins, 6-10 tissue samples could be obtained from each
animal, which allowed the determination of cAMP content in duplicate
samples from the same animal under different conditions. After
preequilibration in Ringer solution for 30 min, the tissues were
transferred to the experimental solutions, which always contained 2 × 10
5 M amiloride, and incubated for 10 min.
Pieces (1.5 cm2) were cut with a cork drill, plunged into
12% ice-cooled trichloroacetic acid, and stored at
18°C until
analysis. cAMP was determined with an ELISA kit including acetylation
(catalog no. DE0450; R&D Systems, Minneapolis, MN). Data are given as
matched pairs based on tissue area.
The xanthine derivatives 3,7-dimethyl-1-propyl xanthine (X-32) and 3,7-dimethyl-1-isobutyl xanthine (X-33), kindly made available by Dr. F. Becq (Laboratoire de Physiologie des Régulations Cellulaires, UMR 6558, Université de Poitiers, Poitiers, France), were dissolved in DMSO. Stock solutions were added to Ringer solution to final concentrations of 2-1,000 µM. IBMX (Sigma) was used at concentrations of 10-500 µM. Furosemide (Sigma) was dissolved in an equimolar amount of 0.1 M NaOH and diluted with Ringer solution to the appropriate concentrations after neutralization. Laboratory chemicals were of analytical grade and were purchased from Sigma.
| |
RESULTS |
|---|
|
|
|---|
Figure 1 shows the record of
voltage-activated GCl in an isolated toad skin
epithelium (split skin) under control conditions and after serosal or
mucosal addition of X-32. The xanthine analog increased
GCl on application to either side. The
stimulation of GCl appeared quickly and was
complete within 3 min. Maximal stimulation was achieved at ~1,000
µM from either side. It was completely reversible on washout, with a
time course similar to that of the onset of action. Because of the use
of the split epithelium devoid of corial connective tissue layers, the
time course of activation and washout was only slightly slower for
serosal than for mucosal application.
|
The concentration-response relationship for the increase in
GCl after addition of X-32 to the mucosal
(n = 7) or serosal (n = 3) side is
shown in Fig. 2. Stimulation was not
notably different for serosal or mucosal application, and the data were
pooled. The sigmoidal regression line indicates that >80% of the
effect was exerted at 300 µM; half-maximal stimulation occurred at
108 ± 9 µM. In seven other experiments, the effect of the
xanthine derivatives X-32 and X-33 on GCl was
tested at 200 µM. Because no difference in efficacy between the
analogs was detected, data obtained with X-32 and X-33 are pooled and
summarized in Table 1. The xanthine
derivatives increased the inactivated tissue conductance (at
30 mV)
only slightly but elevated the voltage-activated GCl (at +80 mV) substantially. For comparison,
the effect of 100 µM IBMX was determined in most of the tissue pieces
(n = 6). This xanthine derivative increased the
baseline and inactivated conductance transiently (not shown) but had
also little influence on the steady-state baseline conductance. In
relative terms, the stimulation of voltage-activated GCl was greater with IBMX than with X-32 and
X-33. The latter were, however, used at less than maximally effective
concentrations. After replacement of mucosal Cl
by
NO

30 or +80 mV (data not shown).
|
|
The stimulation of voltage-activated GCl by
theophylline in the toad skin is associated with a shift of the
G-V relationship (9). The present study showed
that IBMX and the xanthine derivatives without influence on PDE have
similar response patterns. G-V relationships under control
conditions and after application of 200 µM X-32 or 50 µM IBMX are
depicted in Fig. 3. It is evident that
both xanthine analogs, IBMX and X-33, in addition to elevating the maximal level of GCl, shift the G-V
relationship to less negative potentials, i.e., they facilitate voltage
activation. The influence of the xanthine derivatives was readily
reversible on washout (data not shown).
|
Table 2 shows the mean values from 11 experiments with X-32 (300-1,000 µM on the mucosal
side). The data were pooled because no consistent dependence on
concentrations >300 µM X-32 was detectable; at lower concentrations,
the shift of the G-V relationship was smaller but numerical
estimates were not done. On average, the half-maximal voltage for
activation of GCl decreased significantly by
26.5 mV. The maximal level of GCl
increased by 53% compared with control conditions. For comparison,
results from G-V relationships for IBMX (100-300 µM;
n = 5) are included in Table 2. There appears to be no
fundamental difference between the xanthine derivatives, regardless of
their putative influence on the activity of PDE.
|
Furosemide, a blocker of the Na-K-2Cl symport, inhibits
GCl and shifts the G-V relationship
in toad skin to higher voltages when applied from the apical side
(22). Because this is opposite to the influence of the
xanthine derivatives, it was of interest to examine the interaction
between these compounds. Figure 4 shows the record of a typical experiment. G-V relationships were
first recorded under control conditions, then during exposure to 500 µM X-32 on the serosal side, and finally during additional
application of furosemide to the mucosal solution at three different
concentrations. It is interesting to note that the magnitude of
GCl at 80 mV, i.e., the standard activating
voltage, was considerably more affected than the maximally activated
GCl. This is consistent with a shift of the
activation curve, which is confirmed by the G-V
relationships derived from these data as shown in Fig.
5. The voltage of half-maximal activation
was reduced by X-32 from 75.5 to 48.5 mV and increased to 85, 98, and
118 mV under the influence of 300, 600, and 1,000 µM furosemide,
respectively. The changes induced by furosemide in the presence of X-32
are comparable to those observed in the sole presence of the inhibitor,
although the absolute level is shifted to lower voltages. Similar
results were obtained in four other experiments, in which furosemide
was applied in the presence of X-32 and X-33 or IBMX or the xanthines
were added after inhibition with furosemide.
|
|
The content of cAMP in split epithelia from five toad skins was
analyzed under control conditions, with 500 µM X-32, and with 200 µM IBMX. For comparison, tissue pieces from four animals were also
analyzed in the presence of 100 µM forskolin. The results are
summarized in Table 3. In contrast to the
large scatter of the cAMP content in tissues from different animals as
evidenced by the variance of control and experimental data, duplicate
samples from the same animal were rather similar. The ratio of
experimental vs. control content of cAMP in these matched samples
indicates that neither X-32 nor IBMX affected the tissue cAMP content
notably. Forskolin, a direct activator of adenylyl kinase, induced a
>20-fold increase in cAMP content, thus verifying the responsiveness
of the adenylyl cyclase system and the analysis procedure.
|
| |
DISCUSSION |
|---|
|
|
|---|
Because elevation of cellular cAMP (applied as membrane-permeant
analogs) increases GCl in toad skin
(25), this mechanism suggests itself as the explanation
for the stimulation of GCl by the PDE inhibitors
theophylline and IBMX (7, 10, 12). In a more careful
analysis of the response of GCl on cAMP or IBMX, however, we have shown that the response patterns after application of
these two agents are fundamentally different and not compatible with a
common mediation by cAMP (9). Whereas IBMX affects mainly the voltage-activated GCl, cAMP analogs elevate
a baseline conductance, which is poorly Cl
selective and
almost insensitive to voltage in the highly conductive state. On the
basis of these findings, we have proposed that cAMP converts and fixes
the Cl
pathway into a permanently open state, whereas
xanthine derivatives such as theophylline and IBMX increase the
response of GCl to voltage, i.e., sensitize a
component of the conductive Cl
pathway, which we termed
"voltage sensor" (9). Concurrent inhibition of PDE, if
existing, would then be a side effect of no relevant functional
consequence. The present experiments confirm this view. Except for a
lower molar efficacy, the effect on the voltage-activated
GCl of toad skin is identical for IBMX, which is
a putative inhibitor of PDE, and the tested xanthine derivatives X-32
and X-33, which do not inhibit PDE in CHO and Calu-3 cells (2,
3).
For all tested xanthine derivatives, stimulation is limited to a
conductive pathway that depends on the presence of Cl
in
the mucosal solution and is activated by serosa-positive voltages. No
stimulation by any of the xanthine derivatives is observed when the
mucosal Cl
is substituted by SO

-dependent activation site,
although being readily permeant in the open Cl
pathway of
amphibian skin (9). These data indicate that the xanthines stimulate a conductive Cl
influx but cannot
overcome the blockage of the activation site with
NO
In toad skin, neither the xanthine derivative X-32 nor the putative
inhibitor of PDE, IBMX, had any substantial effects on the measured
cAMP content of the tissue when these agents were applied at
concentrations that stimulate GCl maximally.
Responsiveness of the system was confirmed in the present experiments
by the large increase in cAMP content under the influence of the direct activator of adenylyl cyclase, forskolin. Because the data reflect mostly the response of the principal cells, which account for >95% of
the epithelial cells, local changes of the cAMP content, e.g., in
mitochondria-rich cells, might have evaded detection. This could happen
if PDE at these sites were unexpectedly inhibited by the xanthines. We
consider this possibility unlikely, at least for X-32, because the
agreement between our data and those from two other cell types, CHO and
Calu-3 cells (2, 3), suggest a general nonresponsiveness
of PDE to these xanthine derivatives. We therefore conclude, as has
been done for CHO and Calu-3 cells (2, 3), that the
effects of both X-32 and IBMX on GCl originate from a direct interaction of the xanthines with the Cl
pathway and are unrelated to cAMP. We cannot explain why IBMX does not
increase the cAMP content of B. viridis skin. This behavior is unlike the response of frog skin (Rana esculenta), in
which another unspecific inhibitor of PDE, theophylline, increased cAMP by >100% (6).
All tested xanthine derivatives elevated the voltage-activated fraction
of GCl. More specifically, these activators
shift the relationship between conductance and
Vt to lower voltages, i.e., they facilitate the
opening of the Cl
pathway. This concentration-dependent
shift of the G-V relationship to lower activating voltages
can be reversed by furosemide, which inhibits voltage-activated
GCl in toad skin (22) by
interfering with a voltage-sensitive regulator of the conductive
Cl
pathway. This effect of furosemide, which is observed
only after mucosal addition (22), is evidently unrelated
to the Na-K-2Cl cotransporter. This symport is localized to the
basolateral membranes of amphibian skin, and transport occurs in
electroneutral mode. Furthermore, the more powerful inhibitor of the
cotransporter, bumetanide, has negligible effect on the
voltage-activated GCl (22). The
gradual concentration dependence of the G-V relationship on
both the activation by xanthines and the inhibition by furosemide points to interference with a regulatory site of the same pathway rather than induction/disappearance of new pathways.
The reversal of the stimulation induced by X-32 provides further
evidence against involvement of cAMP because an effect of furosemide on
the production of cAMP is highly unlikely and furosemide has no
inhibitory effect on the GCl induced by
membrane-permeant analogs of cAMP (22). It is intriguing
to speculate that xanthines and furosemide affect the same structure,
which controls the voltage sensitivity of the conductance activation,
in an opposite direction, although it is not possible to specify the
location and the chemical nature of this site or the mode of
interference. The questionable role of cAMP in
GCl regulation is illustrated further by the
response of GCl to low concentrations of cAMP
applied as the membrane-permeant, nonmetabolized analog
8-(4-chlorophenylthio)- adenosine 3',5'-cyclic monophosphate
(CPT-cAMP). Although a quantitative numerical correlation is
difficult because of potential differences in affinity, it is clear
that CPT-cAMP has no stimulatory influence on
GCl at concentrations comparable to
physiological levels of cAMP and even 5-10 times higher
(23). At supraphysiological concentrations, however, the
voltage-modulated GCl is replaced by permanent
opening of the conductive Cl
pathway. Accordingly, cAMP
would affect the same Cl
-specific route but via a
different signaling chain from that for the voltage-mediated opening.
Similar to IBMX or theophylline, the xanthine derivatives X-32 and X-33
were evidently without influence on the time course of the increase in
GCl after perturbation of the holding potential from
30 to +80 mV, which leads to activation of Cl
current with half-times of 0.3-2 min in control tissues. This behavior is fundamentally different from the near-instantaneous change
in Cl
current after voltage perturbation in the presence
of high concentrations of cAMP. It is not possible at present to
specify the kind of interaction, particularly as the location of the
Cl
pathway (paracellular across the tight junctions or
transcellular via mitochondria-rich cells) is unknown
(16). Nevertheless, the present findings indicate that
agents in the medium can directly modify the Cl
-specific
sites in this epithelial tissue. Similar conclusions have been derived
from experiments on frog skin with the local anesthetic procaine
(5). For this agent, partition of the uncharged form of
the molecule in the lipid phase of the membrane was proposed to
transfer the effect. It is possible that the same mode of action applies to the xanthine derivatives, which also possess lipophilic properties. Direct binding to regulative sites in the Cl
pathway as proposed for interference with CFTR Cl
channels (3) remains another option. Activation of
Cl
permeability in Calu-3 cells has been associated with
a direct influence of the xanthines on CFTR (2). Although
the presence of CFTR in mitochondria-rich cells of toad skin was
recently demonstrated by immunohistochemical location and PCR
(1), the small quantity of CFTR detected by PCR and its
absence from apical membrane areas cast doubt on the involvement of
this Cl
channel in voltage-activated or cAMP-induced
GCl.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Frederic Becq for the generous gift of the xanthine derivatives X-32 and X-33. Inge Kirmeyer assisted in the experimental work with great engagement, and Dr. John M. Davis improved the language of the manuscript.
| |
FOOTNOTES |
|---|
This work was financially supported by grants from the Deutsche Forschungsgemeinschaft.
Address for reprint requests and other correspondence: W. Nagel, Dept. of Physiology, Schillerstr. 44, 80336 Munich, Germany (E-mail: W.Nagel{at}lrz.uni-muenchen.de).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published October 23, 2002;10.1152/ajpcell.00276.2002
Received 14 June 2002; accepted in final form 16 October 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Amstrup, J,
Frøslev J,
Willumsen NJ,
Møbjerg N,
Jespersen A,
and
Larsen EH.
Expression of cystic fibrosis transmembrane conductance regulator in the skin of the toad, Bufo bufo and possible role for Cl
transport across the heterocellular epithelium.
Comp Biochem Physiol A Mol Integr Physiol
130:
539-550,
2001[Medline].
2.
Bulteau, L,
Derand R,
Mettey Y,
Metaye T,
Morris MR,
McNeilly CM,
Folli C,
Galietta LJV,
Zegarra-Moran O,
Pereira MMC,
Jougla C,
Dormer RL,
Vierfond JM,
Joffre M,
and
Becq F.
Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells.
Am J Physiol Cell Physiol
279:
C1925-C1937,
2000
3.
Chappe, V,
Mettey Y,
Vierfond JM,
Hanrahan JW,
Gola M,
Verrier B,
and
Becq F.
Structural basis for specificity and potency of xanthine derivates as activators of the CFTR chloride channel.
Br J Pharmacol
123:
683-693,
1998[Web of Science].
4.
De Wolf, I,
Van Driessche W,
and
Nagel W.
Forskolin activates gated Cl channels in frog skin.
Am J Physiol Cell Physiol
256:
C1239-C1249,
1989
5.
Flonta, ML,
Endstrasser W,
Kirmeyer I,
and
Nagel W.
Procaine effects on sodium and chloride transport in frog skin.
Pflügers Arch
411:
386-393,
1988[Web of Science][Medline].
6.
Johnsen, AH,
and
Nielsen R.
Theophylline-induced stimulation of sodium transport in frog skin by a mechanism different from the antidiuretic hormone activated pathway.
Acta Physiol Scand
116:
335-341,
1982[Web of Science][Medline].
7.
Katz, U,
and
Larsen EH.
Chloride transport in toad skin (Bufo viridis). The effect of salt adaptation.
J Exp Biol
109:
353-371,
1984
8.
Katz, U,
and
Nagel W.
Biophysics of ion transport across amphibian skin.
In: Amphibian Biology. II. The Integument, edited by Heatwole H,
and Barthalmus GT.. Chipping Norton, UK: Surrey Beatty, 1994, p. 100-121.
9.
Katz, U,
and
Nagel W.
Effects of cyclic AMP and theophylline on chloride conductance across toad skin.
J Physiol
489:
105-114,
1995
10.
Katz, U,
and
Van Driessche W.
Effect of theophylline on the apical sodium and chloride permeabilities of amphibian skin.
J Physiol
397:
223-236,
1988
11.
Kristensen, P.
Is chloride transfer in frog skin localized to a special cell type?
Acta Physiol Scand
113:
123-124,
1981[Web of Science][Medline].
12.
Kristensen, P.
Exchange diffusion, electrodiffusion and rectification in the chloride transport pathway of frog skin.
J Membr Biol
72:
141-151,
1983[Web of Science][Medline].
13.
Kristensen, P,
and
Larsen EH.
Relationship between chloride exchange diffusion and clamping current carried by chloride in the hyperpolarized toad skin (Bufo bufo).
Acta Physiol Scand
102:
22-34,
1978[Web of Science][Medline].
14.
Larsen, EH.
Chloride transport by high-resistance heterocellular epithelia.
Physiol Rev
71:
235-283,
1991
15.
Mills, JW.
Ion transport across the exocrine glands of the frog skin.
Pflügers Arch
405:
S44-S49,
1985[Medline].
16.
Nagel, W,
Davis JM,
and
Katz U.
Transepithelial chloride conductance in amphibian skin: regulatory mechanisms and localization.
Pflügers Arch
440:
797-808,
2000[Web of Science][Medline].
17.
Nagel, W,
and
Dörge A.
Analysis of anion conductance in frog skin.
Pflügers Arch
416:
53-61,
1990[Web of Science][Medline].
18.
Nagel, W,
Garcia-Diaz JF,
and
Essig A.
Contribution of junctional conductance to the cellular voltage-divider ratio in frog skins.
Pflügers Arch
399:
336-341,
1983[Web of Science][Medline].
19.
Nagel, W,
and
Katz U.
Effects of NEM on voltage-activated chloride conductance in toad skin.
J Membr Biol
159:
127-135,
1997[Web of Science][Medline].
20.
Nagel, W,
and
Katz U.
1-Adrenoceptors antagonize activated chloride conductance of amphibian skin epithelium.
Pflügers Arch
436:
863-870,
1998[Web of Science][Medline].
21.
Nagel, W,
and
Katz U.
Trypsin inhibits voltage-activated chloride conductance of toad skin.
Comp Biochem Physiol A Mol Integr Physiol
122:
109-115,
1999[Medline].
22.
Nagel, W,
Somieski P,
and
Katz U.
Selective inhibition of Cl
conductance in toad skin by blockers of Cl
channels and transporters.
Am J Physiol Cell Physiol
281:
C1223-C1322,
2001
23.
Rozman, A,
Gabbay S,
and
Katz U.
Chloride conductance across toad skin: effects of ionic acclimation and cAMP and relation to mitochondria-rich cells.
J Exp Biol
203:
2039-2045,
2000[Abstract].
24.
Willumsen, NJ,
and
Larsen EH.
Passive Cl currents in toad skin: potential dependence and relation to mitochondria-rich cell density.
In: Transport Processes, Ion- and Osmoregulation, edited by Gilles R,
and Gilles-Baillien M.. Berlin: Springer, 1985, p. 20-30.
25.
Willumsen, NJ,
Vestergaard L,
and
Larsen EH.
Cyclic AMP- and
-agonist-activated chloride conductance of a toad skin epithelium.
J Physiol
449:
641-653,
1992
This article has been cited by other articles:
![]() |
M. M. Frigault, J. Lacoste, J. L. Swift, and C. M. Brown Live-cell microscopy - tips and tools J. Cell Sci., March 15, 2009; 122(6): 753 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ben-Shlomo, K. A. Wawrowsky, I. Proekt, N. M. Wolkenfeld, S.-G. Ren, J. Taylor, M. D. Culler, and S. Melmed Somatostatin Receptor Type 5 Modulates Somatostatin Receptor Type 2 Regulation of Adrenocorticotropin Secretion J. Biol. Chem., June 24, 2005; 280(25): 24011 - 24021. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. A. da Silva, J.-M. Zahm, D. Gras, O. Bajolet, M. Abely, J. Hinnrasky, M. Milliot, M. C. de Assis, C. Hologne, N. Bonnet, et al. Dynamic interaction between airway epithelial cells and Staphylococcus aureus Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L543 - L551. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |